Matrix metalloproteinase inhibition in corneal ulceration

Veterinary Clinics of North America - Small Animal Practice

Volumn 34, Issue 3, 2004, Pages 611-622

  Brooks, Dennis E ^a   Ollivier, Frank J ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ANTIBIOTIC AGENT; ASPARTIC PROTEINASE; CHONDROITIN SULFATE; COLLAGEN TYPE 1; COLLAGEN TYPE 12; COLLAGEN TYPE 3; COLLAGEN TYPE 5; COLLAGEN TYPE 6; CYSTEINE PROTEINASE; DOXYCYCLINE; EDETATE DISODIUM; FIBRONECTIN; GELATINASE A; GELATINASE B; GLYCOPROTEIN; ILOMASTAT; KERATAN SULFATE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE; SERINE PROTEINASE; TETRACYCLINE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL DISEASE; ANTIMICROBIAL ACTIVITY; CELL DEGENERATION; CORNEA CELL; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; CORNEA ULCER; ENZYME INHIBITION; FIBROBLAST; HOMEOSTASIS; HORSE; KERATITIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RABBIT; REVIEW; STROMA; TEAR FILM; TISSUE DISTRIBUTION; VETERINARY ANATOMY;

ANIMALS; ANIMALS, DOMESTIC; CORNEAL ULCER; MATRIX METALLOPROTEINASES; OPHTHALMIC SOLUTIONS; PROTEASE INHIBITORS;

EQUUS CABALLUS; ORYCTOLAGUS CUNICULUS;

EID: 1942456565     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2003.12.005     Document Type: Review

References (63)

1. Samuelson D.A. Ophthalmic anatomy In: Gelatt K.N. (Ed.), Veterinary ophthalmology 3rd edition 2002 45-59 Lippincott, Williams - Wilkins Baltimore
2. Records R.E. The tear film In: Tasman W. Jaeger E.A. (Eds.), Duane's clinical ophthalmology on CD-ROM. Foundation vol. 2 2002 Lippincott, Williams - Wilkins Baltimore
3. Slansky H.H. Gnadinger M.C. Itoi M. Dohlman C.H. Collagenase in corneal ulcers Arch Ophthalmol 82 1969 108-111
4. Itoi M. Gnadinger M.C. Slansky H.H. Freeman M.I. Dohlman C.H. Collagenase in the cornea Exp Eye Res 8 3 1969 369-373
5. Strubbe D.T. Brooks D.E. Schultz G.S. Willis-Goulet H. Gelatt K.N. Andrew S.E. et al. Evaluation of tear film proteinases in horses with ulcerative keratitis Vet Ophthalmol 3 2000 111-119
6. Arican M. Ceylan C. Metalloproteinases in canine experimental traumatic keratoconjunctivitis J Vet Med 46 1999 527-532
7. Matsubara M. Zieske J. Fini M.E. Mechanism of basement membrane dissolution preceding corneal ulceration Invest Ophthalmol Vis Sci 32 13 1991 3221-3237
8. Ye H.Q. Azar D.T. Expression of gelatinase A and B, and TIMPS 1 and 2 during corneal wound healing Invest Ophthalmol Vis Sci 39 6 1998 913-921
9. Wong T.T.L. Sethi C. Daniels J.T. Limb G.A. Murphy G. Khaw P.T. Matrix metalloproteinases in disease and repair processes in the anterior segment Surv Ophthalmol 47 3 2002 239-256
10. Xue M. Wakefield D. Willcox M. Lloyd A.R. Di Girolamo N. Cole N. et al. Regulation of MMPs and TIMPs by IL-1β during corneal ulceration and infection Invest Ophthalmol Vis Sci 44 5 2003 2020-2025
11. Fini M.E. Girard M.T. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea Invest Ophthalmol Vis Sci 31 1990 1779-1788
12. Matsubara M. Girard M.T. Kublin C.L. Cintron C. Fini M.E. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea Dev Biol 147 1991 425-439
13. Twining S.S. Regulation of proteolytic activity in tissues Crit Rev Biochem Mol Biol 29 1994 315-383
14. Berman M. Winthrop S. Ausprunk D. Rose J. Langer R. Gage J. Plasminogen activator (urokinase) causes vascularization of the cornea Invest Ophthalmol Vis Sci 22 2 1982 191-199
15. Zieske J.D. Bukusoglu G. Effect of protease inhibitors on corneal epithelial migration Invest Ophthalmol Vis Sci 32 7 1991 2073-2078
16. Barletta J.P. Angella G. Balch K.C. Domova H.G. Stern G.A. Moser M.T. et al. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor Invest Ophthalmol Vis Sci 37 1 1996 20-28
17. Paterson C. Wells J.G. Koklitis P.A. Higgs G.A. Docherty A.J. Recombinant tissue inhibitor of metalloproteinases type 1 suppress alkali-burn-induced corneal ulceration in rabbits Invest Ophthalmol Vis Sci 35 1994 677-684
18. Hibbits K. Hines B. Williams D. An overview of proteinase inhibitors J Vet Intern Med 13 1999 302-308
19. Ollivier F.J. Brooks D.E. Kallberg M.E. Komaromy A.M. Lassaline M.E. Andrew S.E. et al. Evaluation of various compounds to inhibit activity of matrix metalloproteinase activities in the tear film of horses with ulcerative keratitis Am J Vet Res 64 2003 1081-1087
20. Chandler HL, Kusewitt DF, Colitz CMH. Enhanced protease production in refractory corneal ulcers [abstract 914]. In: Proceedings of the Association for Research in Vision and Ophthalmology. Rockville (MD): Association for Research in Vision and Ophthalmology; 2003. p. 37.
21. Brown S. Collagenase and corneal ulcers Invest Ophthalmol Vis Sci 10 1971 203-209
22. Berman M. Collagenase and corneal ulceration In: Woolley D. Evanson J. (Eds.), Collagenase in normal and pathological connective tissues 1980 140-174 John Wiley Chicester
23. Murphy G. Ward R. Hembry R.M. Reynolds J.J. Kuhn K. Tryggvason K. Characterization of gelatinase from pig polymorphonuclear leukocytes: a metalloproteinase resembling tumor type IV collagenase Biochem J 258 1989 463-472
24. Watanabe H. Hattori S. Katsuda S. Nakanishi I. Nagai Y. Human neutrophil elastase: degradation of basement membrane components and immunolocalization in the tissues J Biochem (Tokyo) 108 1990 753-759
25. Morel F. Berthier S. Guillot M. Zaoui P. Massoubre C. Didier F. et al. Human neutrophil gelatinase is a collagenase type IV Biochem Biophys Res Commun 191 1993 269-274
26. Azar D.T. Pluznik D. Jain S. Khoury J.M. Gelatinase B and A expression after laser in situ keratomileusis and photorefractive keratectomy Arch Ophthalmol 116 1998 1206-1208
27. Willeford K.O. Miller W.M. Abrams K.L. Vaughn B.M. Modulation of proteolytic activity associated with persistent corneal ulcers in dogs Vet Ophthalmol 1 1 1998 5-8
28. Sathe S. Sakata M. Beaton A.R. Sack R.A. Identification, origins and the diurnal role of the principle serine protease inhibitors in human tear fluid Curr Eye Res 17 4 1998 348-362
29. Brown S.I. Akiya S. Weller C.A. Prevention of the ulcers of the alkali-burned cornea. Preliminary studies with collagenase inhibitors Arch Ophthalmol 82 1 1969 95-97
30. Li D. Lokeshwar B.L. Solomon A. Monroy D. Ji Z. Pflugfelder S.C. Regulation of MMP-9 production by human corneal epithelial cells Exp Eye Res 73 2001 449-459
31. Clark A. New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology Invest Ophthalmol Vis Sci 39 13 1998 2514-2516
32. Twining S.S. Kirschner S.E. Mahnke L.A. Frank D.W. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins Invest Ophthalmol Vis Sci 34 1993 2699-2712
33. Brown S. Weller C. Akiya S. Pathogenesis of ulcers of the alkali-burned cornea Arch Ophthalmol 83 2 1970 205-208
34. Kenyon K. Berman M. Rose J. Gage J. Prevention of stromal ulceration in the alkali-burned rabbit cornea by glued-on contact lens. Evidence for the role of polymorphonuclear leukocytes in collagen degradation Invest Ophthalmol Vis Sci 18 6 1979 570-587
35. Matsumoto K. Proteases in bacterial keratitis Cornea 19 Suppl 3 2000 S160-S164
36. Sotozono C. Second injury in the cornea. The role of inflammatory cytokines in corneal damage and repair Cornea 19 Suppl 3 2000 S155-S159
37. Kvanta A. Sarman S. Fagerholm P. Seregard S. Steen B. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization Exp Eye Res 70 2000 419-428
38. Ebrahem B, Anand-Apte B. Induction of angiogenesis by active matrix metalloproteinases-2 and 9: role of VEGF [abstract 2906]. In: Proceedings of the Association for Research in Vision and Ophthalmology. Rockville (MD): Association for Research in Vision and Ophthalmology; 2003. p. 119.
39. Brown S.I. Hook C.W. Treatment of corneal destruction with collagenase inhibitors Trans Am Acad Ophthalmol Otolaryngol 75 1971 1199-1207
40. Schultz G.S. Strelow S. Stern G.A. Chegini N. Grant M.B. Galardy R.E. et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases Invest Ophthalmol Vis Sci 33 1992 3325-3331
41. Brown S.I. Weller C.A. The pathogenesis and treatment of collagenase-induced diseases of the cornea Trans Am Acad Ophthalmol Otolaryngol 74 2 1970 375-383
42. Berman M. Collagenase inhibitors: rationale for their use in treating corneal ulceration Int Ophthalmol Clin 15 1975 49-66
43. Berman M. Gordon J. Garcia L.A. Gage L. Corneal ulceration and the serum antiproteases: II. Complexes of corneal collagenases and α-macroglobulins Exp Eye Res 20 3 1975 231-244
44. Brooks D.E. Equine ophthalmology In: Gelatt K.N. (Ed.), Veterinary ophthalmology 3rd edition 1999 1053-1116 Lippincott Williams & Wilkins Philadelphia
45. Ward D. Ocular pharmacology In: Gelatt K.N. (Ed.), Veterinary ophthalmology 3rd edition 1999 336-354 Lippincott Williams - Wilkins Philadelphia
46. Twining S.S. Fukuchi T. Yue B.Y. Wilson P.M. Zhou X. Loushin G. Alpha-2 macroglobulin is present in and synthesized by the cornea Invest Ophthalmol Vis Sci 35 1994 3226-3233
47. Dursun D. Kim M.C. Solomon A. et al. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids Am J Ophthalmol 132 2001 8-13
48. Perry H.D. Hodes L.W. Seedor J.A. et al. Effect of doxycycline hyclate on corneal epithelial wound healing in the rabbit alkali-burn model. Preliminary observations Cornea 12 1993 379-382
49. Golub L.M. Ramamurthy N. McNamara T.F. et al. Tetracyclines inhibit tissue collagenase activity J Periodontal Res 19 1984 651-655
50. Seedor J.A. Perry H.D. McNamara T.F. et al. Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbit Arch Ophthalmol 105 1987 268-271
51. Kanao S. Kouzuki S. Tsuruno M. et al. Clinical application of 3% N-acetylcysteine eye drops in corneal diseases in dogs J Jpn Vet Med Assoc 46 1993 487-491
52. Petroutsos G. Guimaraes R. Giraud J.P. Renard G. Pouliquen Y. Effect of acetylcysteine (Mucomyst) on epithelial wound healing Ophthalmic Res 14 1982 241-248
53. Pfister R.R. Haddox J.L. Dodson R.W. Deshazo W.F. Polymorphonuclear leukocytic inhibition by citrate, other metal chelators, and trifluoperazine. Evidence to support calcium binding protein involvement Invest Ophthalmol Vis Sci 25 1984 955-970
54. Rawal S.Y. Rawal Y.B. Non-antimicrobial properties of tetracyclines-dental and medical implications West Indian Med J 50 2 2001 105-108
55. Pfister R.R. Haddox J.L. Sommers C.I. Effect of synthetic metalloproteinase inhibitor or citrate on neutrophil chemotaxis and the respiratory burst Invest Ophthalmol Vis Sci 38 7 1997 1340-1349
56. Plugfelder SC, Kim HS, Li DQ. Doxycycline inhibits TGF-beta1 stimulated MMP-9 in human corneal epithelial cells via Smad and MAPK pathways [abstract 1404]. In: Proceedings of the Association for Research in Vision and Ophthalmology. Rockville (MD): Association for Research in Vision and Ophthalmology; 2003. p. 57.
57. Wentworth J.S. Paterson C.A. Gray R.D. Effect of a metalloproteinase inhibitor on established corneal ulcers after an alkali burn Invest Ophthalmol Vis Sci 33 7 1992 2174-2179
58. Twining S. Fukuchi T. Yue B. Wilson P. Boskovic G. Corneal synthesis of alpha 1-proteinase inhibitor (alpha 1-antitrypsin) Invest Ophthalmol Vis Sci 35 1994 458-462
59. Prause J.U. Serum albumin, serum antiproteases and polymorphonuclear leucocyte neutral collagenolytic protease in the tear fluid of patients with corneal ulcers Acta Ophthalmol (Copenh) 61 1983 272-282
60. Stangogiannis C, Stangogiannis E, Orellana M, et al. Epithelial promoting agents vs. autologous serum in reepithelialization after experimental mechanical debridement in vivo [abstract 1680]. In: Proceedings of the Association for Research in Vision and Ophthalmology. Rockville (MD): Association for Research in Vision and Ophthalmology; 2002. p. 66.
61. Bron AM, Lafontaine PO, Garcher C. Treatment of persistent corneal epithelial defects by autologous serum [abstract 1693]. In: Proceedings of the Association for Research in Vision and Ophthalmology. Rockville (MD): Association for Research in Vision and Ophthalmology; 2002. p. 67.
62. Garcher C. Pisella P.J. Chapusot C. Lafontaine P.O. Bron A.M. Martin I. et al. Treatment of Gougerot-Sjögren disease by autologous serum [abstract] Invest Ophthalmol Vis Sci 42 4 2001 S32
63. Brooks DE, Ollivier FJ, Schultz GS, Andrew SE, Lassaline ME, Kallberg ME, et al. Duration of in vitro inhibitory activity of equine serum against equine tear film matrix metalloproteinases [abstract 902]. In: Proceedings of the Association for Research in Vision and Ophthalmology. Rockville (MD): Association for Research in Vision and Ophthalmology; 2003. p. 36.